<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9"><gtr:id>4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9</gtr:id><gtr:name>Geron Corporation</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9"><gtr:id>4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9</gtr:id><gtr:name>Geron Corporation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DF50DBA1-B0D1-49BC-BBAB-64BB83E2CE00"><gtr:id>DF50DBA1-B0D1-49BC-BBAB-64BB83E2CE00</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Bruce</gtr:otherNames><gtr:surname>Whitelaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/ED2E5BF1-BE62-4318-AC08-EDC14C791067"><gtr:id>ED2E5BF1-BE62-4318-AC08-EDC14C791067</gtr:id><gtr:firstName>Brendon</gtr:firstName><gtr:otherNames>Stewart</gtr:otherNames><gtr:surname>Noble</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8ED024AE-4123-48A1-A190-A245FD79F567"><gtr:id>8ED024AE-4123-48A1-A190-A245FD79F567</gtr:id><gtr:firstName>Hamish</gtr:firstName><gtr:surname>Simpson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300287"><gtr:id>440F30A4-B226-4D1E-BF8A-E505F7BA56E6</gtr:id><gtr:title>Functional analysis of human embryo-derived stem cells for bone repair</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300287</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>312939</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Geron Corporation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Translational cell therapy research</gtr:description><gtr:id>F9C1361F-0C40-4064-9C7B-89A51907808B</gtr:id><gtr:impact>Patent application
licence agreement</gtr:impact><gtr:piContribution>Cell therapy development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Scottish Stem Cell Network open Workshops - Tissue Engineering Bone and Cartilage 2006</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>D898B87F-2C27-41A5-9F97-D1EB9E318942</gtr:id><gtr:impact>Scottish Stem Cell Network open Workshops - Tissue Engineering Bone and Cartilage 2006 hosted and organised by Brendon Noble

NA</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chief Scientists Office Public Interest Group talk - Repairing bones with stem cells - 2007 Brendon Noble.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>FBD43256-1664-4A2F-8E2E-438F6E00A050</gtr:id><gtr:impact>Chief Scientists Office Public Interest Group talk - Repairing bones with stem cells - 2007 Brendon Noble.

NA</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio Scotland broadcast debate 2008.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>3A5E974E-D899-4DF8-AB2A-705EE24CE57A</gtr:id><gtr:impact>BBC Radio Scotland broadcast debate 2008.

NA</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0650BE22-4302-448F-A8E0-35D6E4C7FD0D"><gtr:id>0650BE22-4302-448F-A8E0-35D6E4C7FD0D</gtr:id><gtr:title>Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42d72e928b31f985ac2f3eeffd8597bd"><gtr:id>42d72e928b31f985ac2f3eeffd8597bd</gtr:id><gtr:otherNames>Forsyth NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7EBA1761-9BAE-47BF-BE81-671A218FE469"><gtr:id>7EBA1761-9BAE-47BF-BE81-671A218FE469</gtr:id><gtr:title>Bone tissue formation from human embryonic stem cells in vivo.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9a7e576956c50550aaaae2b87ddc1d0"><gtr:id>b9a7e576956c50550aaaae2b87ddc1d0</gtr:id><gtr:otherNames>Tremoleda JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300287</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>